Literature DB >> 8501170

Bone mineral density in patients with chronic hypoparathyroidism.

S Abugassa1, J Nordenström, S Eriksson, G Sjödén.   

Abstract

Photon absorptiometry was used to measure skeletal mass in the proximal femur, lumbar spine, and distal radius in 19 females with hypoparathyroidism after operation for either thyroid carcinoma or hyperparathyroidism. Healthy subjects as well as normocalcemic patients who had undergone the same surgical procedure without developing hypoparathyroidism were used as controls. Skeletal mass was measured after a mean postoperative time of 13 and 10 yr in patients operated on for thyroid carcinoma and hyperparathyroidism, respectively. Bone mass was 10-32% greater in hypoparathyroid patients than in controls. In patients with retained parathyroid function after total thyroidectomy and surgical treatment of hyperparathyroidism, bone mass did not differ from that in age-matched healthy controls. Long term T4 medication in doses that suppressed endogenous TSH production was not associated with a decreased bone mass. Reduced PTH production, vitamin D treatment, and calcium supplementation may all have contributed to the increased bone mass found in the patients with postsurgical hypoparathyroidism.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8501170     DOI: 10.1210/jcem.76.6.8501170

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  22 in total

Review 1.  Mini-review: new therapeutic options in hypoparathyroidism.

Authors:  Natalie E Cusano; Mishaela R Rubin; James Sliney; John P Bilezikian
Journal:  Endocrine       Date:  2012-02-07       Impact factor: 3.633

2.  Low bone turnover and increase of bone mineral density in a premenopausal woman with postoperative hypoparathyroidism and thyroxine suppressive therapy.

Authors:  K Amrein; H P Dimai; H Dobnig; A Fahrleitner-Pammer
Journal:  Osteoporos Int       Date:  2010-10-20       Impact factor: 4.507

Review 3.  Hypoparathyroidism.

Authors:  John P Bilezikian
Journal:  J Clin Endocrinol Metab       Date:  2020-06-01       Impact factor: 5.958

Review 4.  Fracture risk in hypoparathyroidism: a systematic review and meta-analysis.

Authors:  R Pal; S K Bhadada; S Mukherjee; M Banerjee; A Kumar
Journal:  Osteoporos Int       Date:  2021-05-22       Impact factor: 4.507

5.  Hypoparathyroidism in the adult: epidemiology, diagnosis, pathophysiology, target-organ involvement, treatment, and challenges for future research.

Authors:  John P Bilezikian; Aliya Khan; John T Potts; Maria Luisa Brandi; Bart L Clarke; Dolores Shoback; Harald Jüppner; Pierre D'Amour; John Fox; Lars Rejnmark; Leif Mosekilde; Mishaela R Rubin; David Dempster; Rachel Gafni; Michael T Collins; Jim Sliney; James Sanders
Journal:  J Bone Miner Res       Date:  2011-10       Impact factor: 6.741

6.  Diabetes and bone fracture: risk factors for old and young.

Authors:  Peter Vestergaard
Journal:  Diabetologia       Date:  2014-07-27       Impact factor: 10.122

7.  PTH(1-84) administration reverses abnormal bone-remodeling dynamics and structure in hypoparathyroidism.

Authors:  Mishaela R Rubin; David W Dempster; James Sliney; Hua Zhou; Thomas L Nickolas; Emily M Stein; Elzbieta Dworakowski; Maryann Dellabadia; Rebecca Ives; Donald J McMahon; Chiyuan Zhang; Shonni J Silverberg; Elizabeth Shane; Serge Cremers; John P Bilezikian
Journal:  J Bone Miner Res       Date:  2011-11       Impact factor: 6.741

8.  Hypoparathyroidism: clinical features, skeletal microstructure and parathyroid hormone replacement.

Authors:  Mishaela R Rubin; John P Bilezikian
Journal:  Arq Bras Endocrinol Metabol       Date:  2010-03

9.  Attenuation of postmenopausal bone loss in patients with transient hypoparathyroidism after total thyroidectomy.

Authors:  Yuuki Takamura; Akira Miyauchi; Tomonori Yabuta; Minoru Kihara; Yasuhiro Ito; Akihiro Miya
Journal:  World J Surg       Date:  2013-12       Impact factor: 3.352

Review 10.  Bone imaging in hypoparathyroidism.

Authors:  B C Silva; M R Rubin; N E Cusano; J P Bilezikian
Journal:  Osteoporos Int       Date:  2016-08-30       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.